DOCS logo

Doximity, Inc. (DOCS) Análisis de Acciones

Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Doximity, Inc. (DOCS) opera en el sector Healthcare, cotizado por última vez a $23.69 con una capitalización de mercado de 5B. La acción obtiene una puntuación de 52/100, una calificación moderada basada en 9 KPI cuantitativos.

Ultimo analisis: 8 feb 2026
Puntuación de IA de 52/100 Objetivo $46.16 (+94.9%) MCap 5B Vol 2M

Doximity, Inc. (DOCS) Resumen de Asistencia Médica y Tuberías

CEOJeffrey A. Tangney
Empleados827
Sede CentralSan Francisco, CA, US
Año de la oferta pública inicial (OPI)2021

Doximity is revolutionizing healthcare communication with its cloud-based platform, connecting medical professionals for enhanced collaboration, patient care, and career development, while boasting impressive financials like a 37.5% profit margin and 89.7% gross margin, making it a compelling investment in the digital health space.

Procedencia de los datos | Datos financieros Análisis cuantitativo NASDAQ Análisis: 8 feb 2026

Tesis de Inversión

Doximity presents a notable research candidate due to its dominant position in the medical professional networking space and its high-margin business model. The company's platform is deeply embedded in the daily workflows of physicians, creating a strong network effect and high barriers to entry. With a market capitalization of $5.21 billion and a P/E ratio of 21.72, Doximity demonstrates financial strength and growth potential. Key value drivers include continued expansion of its user base, increased adoption of its telehealth and advertising solutions, and strategic partnerships with healthcare systems and pharmaceutical companies. The company's impressive gross margin of 89.7% and profit margin of 37.5% highlight its operational efficiency and pricing power. Upcoming catalysts include the further integration of AI-powered tools into the platform and expansion into new medical specialties, solidifying its position as a leader in healthcare technology.

Basado en las finanzas de FMP y el análisis cuantitativo

Puntos clave

  • Market capitalization of $5.21 billion, reflecting strong investor confidence in Doximity's market position and growth prospects.
  • P/E ratio of 21.72, indicating a premium valuation based on its earnings potential and growth trajectory.
  • High gross margin of 89.7%, showcasing the company's efficient cost structure and pricing power in the healthcare technology market.
  • Profit margin of 37.5%, demonstrating strong profitability and effective management of operating expenses.
  • Beta of 1.39, suggesting higher volatility compared to the market, potentially offering greater returns but also increased risk.

Competidores y Pares

Fortalezas

  • Dominant position in the medical professional networking space.
  • High gross and profit margins.
  • Strong network effect and user engagement.
  • Comprehensive platform with a wide range of features.

Debilidades

  • Reliance on advertising revenue, which can be cyclical.
  • Limited geographic diversification, primarily focused on the United States.
  • Potential for increased competition from larger technology companies.
  • Vulnerable to changes in healthcare regulations and policies.

Catalizadores

  • Ongoing: Continued expansion of telehealth services driving increased user engagement and revenue.
  • Upcoming: Integration of AI-powered tools to enhance platform functionality and improve user experience.
  • Ongoing: Strategic partnerships with healthcare systems to expand reach and market penetration.
  • Upcoming: Launch of new features and services tailored to specific medical specialties.

Riesgos

  • Potential: Increased competition from larger technology companies entering the healthcare market.
  • Potential: Data security and privacy breaches compromising user data and damaging reputation.
  • Ongoing: Changes in healthcare regulations and reimbursement policies impacting revenue streams.
  • Potential: Economic downturn leading to reduced advertising spending from pharmaceutical manufacturers.

Oportunidades de crecimiento

  • Expansion of Telehealth Services: Doximity has the opportunity to further expand its telehealth offerings, capitalizing on the increasing demand for virtual patient visits. The telehealth market is projected to reach $285.7 billion by 2027, presenting a significant growth opportunity for Doximity. By enhancing its virtual visit platform and integrating it with other clinical workflows, Doximity can attract more physicians and patients, driving revenue growth and solidifying its position in the telehealth market.
  • Increased Adoption of Advertising Solutions: Doximity can leverage its extensive network of medical professionals to drive increased adoption of its advertising solutions among pharmaceutical manufacturers and healthcare systems. The digital health advertising market is estimated to be worth billions of dollars annually. By offering targeted advertising campaigns and demonstrating the effectiveness of its platform in reaching physicians, Doximity can capture a larger share of this market and generate substantial revenue growth.
  • Strategic Partnerships with Healthcare Systems: Doximity can forge strategic partnerships with healthcare systems to integrate its platform into their existing workflows and electronic health record systems. These partnerships can provide Doximity with access to a larger pool of physicians and patients, driving user growth and increasing platform engagement. By collaborating with healthcare systems, Doximity can also develop customized solutions that address their specific needs, further strengthening its competitive advantage.
  • Integration of AI-Powered Tools: Doximity can integrate AI-powered tools into its platform to enhance its functionality and improve the user experience. AI can be used to automate tasks, personalize content, and provide insights to physicians, making the platform more valuable and engaging. By leveraging AI, Doximity can differentiate itself from competitors and attract more users, driving revenue growth and solidifying its position as a leader in healthcare technology.
  • Expansion into New Medical Specialties: Doximity can expand its platform to include new medical specialties, broadening its reach and increasing its user base. By tailoring its platform to the specific needs of different specialties, Doximity can attract more physicians and generate additional revenue streams. This expansion can be achieved through targeted marketing campaigns, partnerships with medical associations, and the development of specialty-specific content and tools.

Oportunidades

  • Expansion into new medical specialties and geographic markets.
  • Increased adoption of telehealth and virtual care solutions.
  • Strategic partnerships with healthcare systems and pharmaceutical companies.
  • Integration of AI-powered tools to enhance platform functionality.

Amenazas

  • Increased competition from existing and new players in the healthcare technology market.
  • Data security and privacy breaches.
  • Changes in healthcare regulations and reimbursement policies.
  • Economic downturn impacting advertising spending.

Ventajas competitivas

  • Strong network effect due to its large and engaged user base of medical professionals.
  • High switching costs for users who have integrated the platform into their daily workflows.
  • Proprietary technology and data analytics capabilities.
  • Established brand reputation and trust within the medical community.

Acerca de DOCS

Doximity, Inc., initially founded as 3MD Communications, Inc. before rebranding in June 2010, emerged in 2010 with a vision to transform how medical professionals connect and collaborate. Headquartered in San Francisco, Doximity has established itself as a leading cloud-based digital platform tailored for the specific needs of physicians and healthcare providers across the United States. The platform offers a suite of tools designed to streamline workflows, enhance communication, and facilitate continuous learning. Doximity's core offerings include secure messaging for HIPAA-compliant communication, a virtual patient visit platform for telehealth consultations, and a comprehensive medical news feed to keep members updated on the latest research and clinical advancements. Furthermore, the platform provides career management resources, enabling physicians to explore job opportunities and advance their professional development. Doximity primarily serves pharmaceutical manufacturers and healthcare systems, offering targeted advertising and marketing solutions through its extensive network of medical professionals. With 827 employees, Doximity continues to innovate and expand its platform to meet the evolving needs of the healthcare industry.

Qué hacen

  • Provides a cloud-based digital platform for medical professionals.
  • Enables collaboration among physicians and healthcare providers.
  • Facilitates coordination of patient care through secure messaging and virtual visits.
  • Offers a virtual patient visit platform for telehealth consultations.
  • Delivers up-to-date medical news and research to its members.
  • Provides career management resources for physicians.
  • Connects pharmaceutical manufacturers and healthcare systems with medical professionals for targeted advertising.

Modelo de Negocio

  • Subscription fees from healthcare systems for access to the platform and its features.
  • Advertising revenue from pharmaceutical manufacturers targeting physicians.
  • Revenue from virtual patient visit platform usage.
  • Data analytics and insights services for healthcare organizations.

Contexto de la Industria

Doximity operates within the rapidly growing healthcare information services industry, driven by the increasing adoption of digital health technologies and the need for improved communication and collaboration among healthcare professionals. The market is characterized by intense competition, with companies vying for market share in telehealth, electronic health records, and medical networking. Doximity's focus on providing a comprehensive platform specifically tailored for physicians gives it a competitive edge. The industry is expected to continue its growth trajectory, fueled by factors such as the aging population, rising healthcare costs, and advancements in technology.

Clientes Clave

  • Physicians and other medical professionals.
  • Pharmaceutical manufacturers.
  • Healthcare systems.
  • Medical associations.
Confianza de la IA: 74% Actualizado: 8 feb 2026

Finanzas

Gráfico e información

Precio de la acción de Doximity, Inc. (DOCS): $23.69 (-0.62, -2.55%)

Últimas noticias

Consenso de analistas

Calificación de Consenso

Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para DOCS.

Objetivos de Precios

Objetivo de consenso: $46.16

MoonshotScore

52/100

¿Qué significa esta puntuación?

El MoonshotScore califica el potencial de crecimiento de DOCS en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.

Acciones de Doximity, Inc.: Preguntas Clave Respondidas

¿Cuáles son los factores clave para evaluar DOCS?

Doximity, Inc. (DOCS) actualmente tiene una puntuación IA de 52/100, indicando puntuación moderada. La acción cotiza a un P/E de 18.6x, por debajo del promedio del S&P 500 (~20-25x), potencialmente señalando valor. Los analistas apuntan a $46.16 (+95% desde $23.69). Fortaleza clave: Dominant position in the medical professional networking space.. Riesgo principal a monitorear: Potential: Increased competition from larger technology companies entering the healthcare market.. Esto no es asesoramiento financiero.

¿Qué es el MoonshotScore de DOCS?

DOCS actualmente puntúa 52/100 (Grado C) en el MoonshotScore, lo que sugiere calificación moderada. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.

¿Con qué frecuencia se actualizan los datos de DOCS?

Los precios de DOCS se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.

¿Qué dicen los analistas sobre DOCS?

Los analistas han establecido un precio objetivo de consenso de $46.16 para DOCS, representando un potencial alcista del 95% desde el precio actual de $23.69. La cobertura incluye calificaciones de compra, mantener y venta, estimaciones de ganancias y recientes mejoras o rebajas. Consulte la sección de Consenso de Analistas en esta página.

¿Cuáles son los riesgos de invertir en DOCS?

Las categorías de riesgo para DOCS incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Increased competition from larger technology companies entering the healthcare market.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.

¿Cuál es la relación P/E de DOCS?

Doximity, Inc. (DOCS) tiene una relación P/E de 18.6, que está por debajo del promedio del mercado, lo que puede sugerir valor relativo. La relación P/E compara el precio de la acción con sus ganancias por acción. Compare con el promedio del S&P 500 (~20-25x) para contexto. Esto no es asesoramiento financiero.

¿Está DOCS sobrevalorada o infravalorada?

Determinar si Doximity, Inc. (DOCS) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Su relación P/E es 18.6. Objetivo de analistas $46.16 (+95% desde el precio actual). Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.

¿Cuál es el rendimiento por dividendo de DOCS?

Doximity, Inc. (DOCS) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.

Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.

Recursos Oficiales

Análisis actualizado el Puntuación de IA actualizada diariamente
Fuentes de Datos y Metodología
Datos de mercado proporcionados por Financial Modeling Prep y Yahoo Finance. Análisis de IA por algoritmos propietarios de Stock Expert AI. Indicadores técnicos mediante cálculos estándar de la industria. Última actualización: .

Datos proporcionados solo con fines informativos.

Notas de análisis
  • Information is based on available data as of 2026-02-08. Market conditions and company performance may change over time.
Fuentes de datos

Popular Stocks